Ori Biotech raises over $100 million in Series B funding to launch innovative cell and gene therapy manufacturing platform

LONDON, Jan. 18, 2022 /PRNewswire/ -- Ori Biotech Ltd. (Ori), a leader in cell and gene therapy (CGT) manufacturing technology, today announces it...

Related Keywords

London ,City Of ,United Kingdom ,Farlan Veraitch ,Bruce Levine ,Stuart Milne Cytiva ,Anthony Davies ,Jason Jones Miltenyi ,Abu Dhabi ,Barry Clare ,Lee Unroe Indivior ,Paul Meister Thermofisher ,Paul Meister ,Robert Preti ,Chris Mason ,Kevin Gordon Tmunity ,Jasonc Foster ,Jasonc Foster Indivior ,Tom Heathman Minaris ,Novalis Lifesciences ,Neil Hunter Michelle Boxall ,David Smith Minaris ,Lightspeed Early Access Program ,Academic Medical Centers ,Ori Biotech Ltd ,Image Box Communications ,Ori Biotech ,Puhua Capital ,Chimera Abu Dhabi ,Amadeus Capital Partners ,Delin Ventures ,Northpond Ventures ,Octopus Ventures ,Lori Board ,Novalis Lifesciences Investments ,Chief Scientific Officer Farlan ,London And New Jersey Based ,Annalisa Jenkins ,Dimension Therapeutics ,Life Science ,